how many people are on glp 1 drugs The Evolution of GLP-1 Users GLP-1 Antagonists Increase Plan Drug
Description
515,516,517 GLP-1 may improve the livers antioxidant capacity and metabolic function by activating Sirt1, thereby helping to alleviate the pathological changes associated with NASH
Obesity and weight loss in idiopathic intracranial hypertension: a narrative review
Obesity alone increases the risk of headache and migraine by 27%, suggesting that weight loss itself is an important goal in the symptomatic treatment of IIH (20)
Cons: Higher risk of initial stomach upset
These are less likely to happen when the dose is started low and increased slowly, and they usually get better over time
